Biogen and City Therapeutics: No Recent RNAi Partnership Noted

Published 1 days agoBIIB

As of May 27, 2025, there is no publicly available information about a collaboration between Biogen and City Therapeutics to develop RNA interference (RNAi) therapies. While both companies are active in the biotech field, this specific partnership has not been reported.

City Therapeutics has been focusing on strategic collaborations with other companies, like Bausch + Lomb, in developing RNAi-based treatments for retinal diseases, including geographic atrophy. Meanwhile, Biogen has forged partnerships, such as the one with C4 Therapeutics, to innovate in neuroscience drug discovery, Reuters reported.

The absence of a partnership between Biogen and City Therapeutics for RNAi therapies does not overshadow the strategic alliances each company has formed in their respective areas. These partnerships highlight ongoing efforts to advance medical treatments through novel biotechnological approaches.

Share this article

Twitter Facebook LinkedIn

Recent Articles

Flushing Financial Declares $0.22 Quarterly Dividend

9 minutes agoFFIC

Flushing Financial Corporation has announced a quarterly dividend of $0.22 per share. This payment is set for June 20, 2025, targeting shareholders who are registered by June 10, 2025. This decision reflects the company's ongoing commitment to providing consistent returns to its investors. This marks the corporation's 116th consecutive quarterly dividend since their inaugural payment in 1996, according to the company's dividend history. The dividend amount remains unchanged from previous quarters, maintaining a steady distribution for shareholders. Looking ahead, CEO John R. Buran conveyed expectations of enhanced financial performance in 2025, emphasizing improved net interest margin and profitability. He also highlighted the importance of strong liquidity, capital preservation, and credit discipline as key factors driving future success, as reported by Nasdaq.

Stellantis Names Antonio Filosa as New CEO in Strategic Leadership Change

24 minutes agoSTLA

Automaker Stellantis has announced the appointment of Antonio Filosa as its new Chief Executive Officer, effective June 23, 2025. This leadership change follows the resignation of former CEO Carlos Tavares in December 2024, amid challenges including significant declines in both profits and sales. Filosa, who currently leads Stellantis' North American operations, takes the helm as the company seeks to enhance its competitive edge in the automotive market. Antonio Filosa, 51, brings over 25 years of experience in the automotive industry to his new role. His career began at Fiat in 1999, and he has since held numerous key positions, such as Chief Operating Officer for South America and global head of the Jeep brand. Reuters highlights Filosa's deep understanding of Stellantis' operations, which is expected to drive strategic initiatives to restore the company's financial health. With a focus on revitalizing Stellantis' presence in the U.S. market, Filosa will tackle a 70% drop in net profits and address a €6 billion cash burn experienced in 2024. He also plans to streamline the automaker's extensive 14-brand portfolio and improve relations with dealers, unions, and governments. Stellantis was formed in 2021 from the merger of Fiat Chrysler and PSA Group, encompassing well-known brands such as Peugeot and Jeep.

Inseego Corp. Joins Russell 3000 Index

39 minutes agoINSG

Inseego Corp. has been added to the prestigious Russell 3000® Index, taking effect after the U.S. market opens on July 1, 2019. Joining this index places Inseego among the 3,000 largest publicly held companies in the U.S., a significant recognition of its growth and prominence in the telecommunications industry. The inclusion in the Russell 3000® Index is anticipated to boost Inseego's visibility within the investment community. Such exposure is likely to attract more investor interest as the Russell 3000® serves as a benchmark for about 98% of the entire U.S. stock market, according to Inseego's report. This is not the first time the company, previously known as Novatel Wireless, Inc., has featured in the index. Reuters reported that the predecessor entity was added to the index back on June 25, 2004. The current inclusion underscores Inseego's continued relevance and strategic development within the market.

Toyota Expands Hybrid Vehicle Focus with Major U.S. Strategy Shift

54 minutes agoTM

Toyota is ramping up its commitment to plug-in hybrid vehicles, aiming for these models to make up 20% of its U.S. sales by 2030. In a significant move, the automaker announced in October 2023 an $8 billion investment in its North Carolina battery plant, doubling its previous commitment. This expansion aims to support the production and sales of 1.5 to 1.8 million electric or hybrid vehicles annually in the U.S. by the end of the decade, ultimately creating over 5,000 jobs by 2025. This strategic shift is part of Toyota's plan to offer hybrid-only versions of many models, like the 2025 Camry and the 2026 RAV4, aligning with its multi-pathway approach. By introducing more plug-in hybrid models, Toyota seeks to provide extended electric-only driving ranges ahead of new U.S. carbon emissions standards set for 2027. As reported by CBT News, the company's focus on hybrids is a strategic response to challenges faced by the electric vehicle market, including high costs and infrastructure hurdles. As of June 2023, hybrids made up 37% of Toyota's U.S. sales, a steep climb from 9% in 2018. This growth trajectory reflects Toyota's strategy to capitalize on existing market demand while preparing for more advanced EV development. Reuters highlighted Toyota's pragmatic approach amid fluctuating electric vehicle demand, emphasizing the hybrid route as a flexible solution to shifting consumer and regulatory landscapes.